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Renal ATP binding cassette (ABC) transporters have an
important role in the elimination of metabolic waste
products and compounds foreign to the body. The kidney
has the ability to tightly control the expression of these efflux
transporters to maintain homeostasis, and as a major
mechanism of adaptation to environmental stress. In the
present study, we investigated the expression of 45 ABC
transporter genes in the mouse kidney under basal
conditions, after induction of ischemia and after
regeneration. Two days after clamping, mice showed a 76%
decrease in renal creatinine clearance, which improved
clearly within 7 days. This was confirmed by histological
examinations. Seven days after ischemia, real-time
quantitative Polymerase chain reaction data showed that
transcript abundance of abcb1, abcb11, and abcc4 was
increased, and that of abca3, abcc2, and abcg2 decreased.
Expression of all transporters returned to baseline after 14
days, except for abcb11, which was reduced. Abcb11 is the
major liver canalicular bile salt export pump. Here we show
for the first time expression in the kidney and localization of
the transporter to the apical membrane of proximal tubules.
The presence of another novel renal transporter, abca3, was
confirmed by Western blotting. Immunohistochemistry
showed that abca3 is localized to the peritubular capillaries
and apical membrane of proximal tubules. In conclusion,
after inducing ischemic reperfusion injury in the kidney, ABC
transporters appear to be differentially regulated, which
might be associated with the renal regeneration process.
Furthermore, we showed for the first time expression and
subcellular localization of abcb11 and abca3 in mouse
kidney.
Kidney International (2006) 69, 2186–2193. doi:10.1038/sj.ki.5000407;
published online 12 April 2006
KEYWORDS: acute renal failure; renal protection; ABC transporter; expression
Members of the ATP binding cassette (ABC) superfamily of
transporters are expressed in almost all tissues and cells where
many of them are involved in the cellular defense against
endogenous and exogenous xenobiotics, and their meta-
bolites.1,2 Their overexpression in tumor cells is associated
with multidrug resistance, which is a major complication for
successful cancer chemotherapy. The transport proteins
couple ATP hydrolysis to the transport of specific substrates.
In excretory organs, like the kidney, ABC transporters have
an important role in the elimination of metabolic waste
products and compounds foreign to the body. The kidney has
the ability to optimize the effectiveness of the excretory
systems through a dynamic functional regulation at trans-
criptional and post-transcriptional levels in order to maintain
homeostasis.3 Under pathological conditions, waste products
and xenobiotics may accumulate in the kidney owing to
tubular dysfunction,4 and there is increasing evidence from
animal models that the expression level of efflux transporters
is tightly controlled as a major mechanism of adaptation to
environmental stress.5
In addition to their efflux function, ABC transporters have
been implicated in cellular protection against apoptosis and
hypoxic damage.6,7 Furthermore, they have been associated
with cell proliferation and differentiation in regeneration of,
among others, liver, heart, and skeletal muscle9–11 but it is
unknown whether they play a role in kidney repair after renal
injury. For a few ABC transport proteins, differential
expression was found following renal injury. After induction
of acute renal failure in rats, a decrease in Abcb1 protein
levels was observed in the kidney, whereas the expression in
liver and brain was unchanged.12 In contrast, using
nephrectomy as a model of chronic renal failure in rats
in vivo, Laouari et al.13 showed that renal Abcb1 mRNA
expression levels were unchanged 3 weeks and significantly
increased 6 weeks after nephrectomy. However, protein levels
remained unchanged during both periods. On the other
hand, Abcc2 protein and mRNA levels were clearly elevated
in kidney and liver, possibly as an adaptive response to
elevated levels of circulating toxins.13
The present study was designed to evaluate the renal
expression of 45 different ABC transporters after damage of
the mouse kidney. One of the most frequently occurring
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clinical problems concerning the kidney is acute kidney
injury, which is associated with a high morbidity and
mortality. Because of the necrosis of renal tubules observed,
the clinical phenomenon is termed acute tubular necrosis.
Renal tubular cells are very sensitive to oxygen deprivation,
therefore, ischemic insults, especially in combination with
potentially toxic drugs, are the most important causes of
acute tubular necrosis. Ischemia may be a result of operative
crossclamping of the aorta and/or renal arteries leading to
necrosis in certain segments of the proximal tubule and to a
lesser extent the thick ascending limb.4 Despite the high
vulnerability of the kidney to ischemia and toxicity, the organ
has a natural ability to recover and regenerate after acute
damage. Dedifferentiation of glomerular and tubular cells to
a more embryonic/mesenchymal phenotype represents a key
process for recovery in response to damage.14 Whether ABC
transporters play a role in the renal recovery process is yet
undefined. After applying ischemia–reperfusion injury to
mouse kidneys, we found that a number of ABC transporters
are differentially regulated, which might be associated with
renal regeneration. Furthermore, we show for the first time
expression and localization of abcb11 and abca3 in mouse
kidney.
RESULTS
Ischemic–reperfusion injury in the kidney
Histological examination 2 days after inducing renal ischemia
revealed serious damage to the proximal tubules, compared
to the control (Figure 1a). Loss of proximal tubule cells and
loss of brush border membranes caused tubular obstruction
(arrows in Figure 1b). After 7 days, recovery of the proximal
tubules was observed. New brush border membranes were
formed but also cast formation was seen (arrows in Figure
1c). Finally, after 14 days, the proximal tubules were almost
fully recovered (arrows in Figure 1d).
Blood and urine samples were collected 24 h before and 2
and 7 days after surgery, and creatinine concentrations were
determined. After 2 days, creatinine clearance decreased
significantly by 75% (one-way analysis of variance), and
recovered partially to a level of 60% 7 days after ischemia as
compared to the normal baseline creatinine clearance in
sham-operated mice (Figure 2).
Gene expression in the mouse kidney before and after
ischemia
In mice, 51 members of the abc family have been identified,
which show high concordance with their corresponding
human gene orthologs. The ABC family is divided into
seven classes (A–G) of which the A and C classes contain the
largest number of members (12 each). The expression
patterns of 48 different transporter genes were assessed
by real-time quantitative PCR (RQ-PCR). Their expression
was normalized for the average cycle threshold (CT) value
for the housekeeping gene, glyceraldehyde-3-phosphate
dehydrogenase (CT¼ 19.270.48, n¼ 16), and expressed as
delta CT values. Glyceraldehyde-3-phosphate dehydrogenase
expression remained stable after inducing ischemia
(CT¼ 19.870.32, n¼ 16) and during the recovery period
(CT¼ 19.170.19, n¼ 16). Other housekeeping genes,
glucuronidase and hypoxanthine guanine phosphoribosyl
transferase 1, gave comparable values to glyceraldehyde-3-
phosphate dehydrogenase (data not shown). Table 1 presents
the expression values of the transporter genes before
(control) and 7 and 14 days after the induction of ischemia.
Measuring the expression values 2 days after ischemia was not
possible because of the poor quality of the mRNA.
Transporters that showed a high gene expression in controls
are abca3, abcc2, abcd3, abcd4, and abcg2 with DCT values
varying between 2.1 and 4.1. After ischemic injury, several
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Figure 1 | Histopathology of the mouse kidney. Characteristic
histologic signs of renal injury and regeneration after an ischemic
insult. (a) Control kidney slice showing a glomerulus (G) surrounded
by proximal tubules (P). (b) Two days after bilateral clamping of the
renal artery and vein for 30 min, serious damage to the proximal
tubules (P) is observed with debris in tubular lumen (indicated by
arrows). (c) Seven days after the insult, the tubules are partially
recovered as can be concluded from repaired brush border
membranes (indicated by arrows). (d) Almost completely restored
tubular segments (indicated by arrows) were found after 14 days.
Original magnification, (all the figures)  400 .
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Figure 2 | Effect of kidney ischemia–reperfusion on renal
creatinine handling. Creatinine clearances from sham-operated
mice and mice that underwent bilateral ischemia for 30 min followed
by 7 days of recovery. Data are presented as mean7s.e.m. of eight
independent experiments. *Significantly different from basal value
(Po0.001).
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transporter genes were upregulated (i.e. at least a two times
higher expression) or downregulated (at least a two times
lower expression) compared to control values from sham-
operated animals.15 Fourteen days after ischemia, the
expression levels of all genes returned to baseline except for
abcb11, which was downregulated. Based on their variable
expression pattern or remarkably high expression in the
kidney, the transporter gene products of abca3, abcb1a/b,
abcc2, abcc4, and abcb11 were investigated further.
Furthermore, the expression of the transcription factor,
nuclear factor-kB (NF-kB), was investigated. Gene expression
was induced 7 days after ischemia (DCT: 1.9670.52 vs
4.2670.98). Fourteen days after the ischemic insult, still an
increased expression of NF-kB was observed (DCT:
1.6670.36).
Protein expression
Seven days after inducing ischemia, we performed Western
blotting to determine the protein expression of abca3,
abcb1a/b, abcb11, abcc2, abcc4, and abcg2. The presence
and localization of abca3 (150 kDa) in the kidney has, as yet,
not been described. Figure 3a shows that after inducing
ischemia, abca3 was downregulated. On the other hand,
abcb1, with a size of approximately 140 kDa, was clearly
upregulated (Figure 3b). Abcb11 is the major liver canalicular
bile salt export pump; however, its expression in the kidney
Table 1 | ABC transporter gene expression along the kidney after inducing ischemia
ABC transportera Delta CT values
b
Gene symbol Assay Ids FVB controls FVB 7 days after ischemia FVB 14 days after ischemia
Abca1 Mm00442646_m1 6.470.11 4.170.42 6.970.10
Abca2 Mm00431553_m1 6.270.02 7.470.95 7.070.66
Abca3 Mm00550501_m1 2.170.56 3.970.82 2.270.25
Abca4 Mm00492004_m1 9.370.12 12.570.38 8.870.46
Abca5 Mm00461656_m1 6.970.18 7.570.34 7.570.44
Abca6 Mm00461636_m1 11.070.07 8.770.54 11.670.11
Abca7 Mm00497010_m1 5.670.06 5.470.94 6.670.77
Abca8a Mm00462440_m1 9.570.26 8.270.32 7.970.13
Abca8b Mm00457361_m1 10.170.04 9.470.68 10.970.06
Abca9 Mm00461704_m1 8.070.22 7.270.31 8.270.65
Abcb1a Mm00440761_m1 9.270.03 9.470.07 9.470.25
Abcb1b Mm00440736_m1 11.070.35 8.770.13 8.770.41
Abcb4 Mm00435630_m1 14.370.02 9.070.03 12.670.62
Abcb6 Mm00470049_m1 6.170.28 7.370.19 6.970.97
Abcb9 Mm00498197_m1 8.170.44 9.570.15 8.570.58
Abcb10 Mm00497927_m1 7.570.26 8.470.23 8.470.60
Abcb11 Mm00445168_m1 11.470.23 5.470.56 21.270.09
Tap1 Mm00443188_m1 6.870.03 4.370.06 8.070.17
Tap2 Mm00441668_m1 6.570.26 5.770.35 7.070.58
Abcc1 Mm00456156_m1 6.770.29 5.670.28 7.470.12
Abcc2 Mm00496899_m1 4.170.08 6.170.98 4.570.37
Abcc3 Mm00551550_m1 10.170.18 7.170.11 11.170.07
Abcc4 c 7.170.25 6.070.21 6.870.67
Abcc5 Mm00443360_m1 7.370.23 7.470.04 8.370.09
Abcc8 Mm00803450_m1 11.070.19 12.370.39 14.570.83
Abcc9 Mm00441638_m1 6.770.21 6.770.09 7.070.10
Abcc10 Mm00467403_m1 6.570.32 7.570.08 8.070.28
Abcd1 Mm00431749_m1 6.370.51 6.370.05 7.570.24
Abcd2 Mm00496455_m1 8.570.21 8.670.21 10.170.18
Abcd3 Mm00436150_m1 3.570.31 4.870.18 3.270.21
Abcd4 Mm00436180_m1 4.170.47 5.770.32 4.470.19
Abce1 Mm00649858_m1 3.570.05 5.570.59 6.770.14
Abcf2 Mm00457400_g1 6.370.21 6.470.36 6.170.13
Abcf3 Mm00658695_m1 6.370.17 7.070.21 7.970.44
Abcg1 Mm00437390_m1 6.770.28 5.370.09 7.470.27
Abcg2 Mm00496364_m1 2.270.18 4.870.31 3.370.28
Abcg3 Mm00446072_m1 12.970.63 9.970.57 13.170.13
Abcg4 Mm00507250_m1 14.570.18 12.370.27 15.570.33
Abcg5 Mm00446249_m1 15.270.09 11.770.48 15.070.31
dAbcg8 Mm00445970_m1 20.670.41 15.970.26 21.270.78
ABC, ATP binding cassette; FVB, friend leukaemia virus B strain.
aGene expression values of different ABC transporters (http://nutrigene.4t.com/humanabc.htm) in the mouse kidney before inducing ischemia and 7 and 14 days after
inducing ischemia.
bData of 16 pooled samples, measured in duplicate, are given.
cPrimers and probe designed by PrimerExpress Software, version 1.5 (Applied Biosystems; see Materials and Methods section).
dLow-expressed transport protein: CT value is not considered as valid.
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was not detected until now. Our Western blot results
confirmed the RQ-PCR data and showed that the transport
protein is present in the mouse kidney, but, in contrast with
its gene expression, the protein disappeared within 7 days
after renal injury (Figure 3c). Both abcc2 and abcc4 showed a
slight downregulation (Figure 3d and e), whereas the
expression of abcg2 was upregulated after inducing renal
injury (Figure 3f).
Immunohistochemistry
Because RQ-PCR data and Western blotting revealed two
ABC transporters that have not been described before in the
kidney, namely abca3 and abcb11, we investigated their renal
distribution in more detail. Immunohistochemical analysis
indicated that abca3 is localized in the peritubular capillaries
of the kidney (Figure 4a and b). After counterstaining against
heparan sulfate (Figure 4a and b), a specific staining of the
abca3 transporter was observed in the apical membrane of
several segments of the proximal tubule. Furthermore,
Bowman’s capsule appeared to express abca3.
Figure 4c and d shows expression of abcb11 in the kidney.
The transporter was found to be localized to the apical
membranes of the proximal tubules (Figure 4c and d),
which indicates that abcb11 may function as a urinary efflux
pump.
The localization of Abcc4/abcc4 to the apical membranes
of renal proximal tubules has been described previously;16,17
however, its segmental distribution is unknown. A represen-
tative immunohistochemical image (Figure 4e) indicates
that the protein is expressed in all the segments of the
proximal tubule. Finally, the expression of abcg2 was
investigated. After counterstaining with Naþ ,Kþ -ATPase,18
a clear apical staining of abcg2 in the proximal tubules is
observed (Figure 4f).
DISCUSSION
In the present study, we investigated the gene expression
profile of ABC transporters after ischemia–reperfusion injury
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Figure 3 | Immunoblot analyses of ABC proteins in FVB mice
before and 7 days after inducing ischemia. Total membrane
fractions of mice kidneys were isolated and analyzed for expression of
(a) abca3, (b) abcb1, (c) abcb11, (d) abcc2, (e) abcc4, and (f) abcg2.
Values are means7s.e., n¼ 4, where pixel intensity (arbitrary units)
was set at 1.0 in the control. Significantly different from control
(*Po0.05, **Po0.01, ***Po0.001).
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Figure 4 | Renal distribution of mouse abca3, abcb11, and abcg2.
(a) Representative immunohistochemical images show that abca3 is
expressed in the peritubulary capillaries (indicated by arrows) and the
apical membranes of the proximal tubules (*). (b) In addition, abca3 is
expressed in Bowman’s capsule (B). (c and d) Abcb11 is expressed in
the apical membrane of the proximal tubules, as observed using two
different antibodies (c: antibody from Kamiya Biomedical Company,
Seattle, WA, USA; (d) antibody from professor Dr B Stieger, University
Hospital Zu¨rich, Switzerland). (e) Abcc4 expression seen in the apical
membrane of the proximal tubules. (f) After double staining with
Naþ , Kþ -ATPase, which is localized to the basolateral membrane, it is
clear that abcg2 is expressed in the apical membrane of the proximal
tubules. G, glomerulus; B, Bowman’s capsule, P, proximal tubule, D,
distal tubule (original magnification, (a and b)  500; (c)  200; (d–f)
 400).
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in the mouse kidney. Histological and functional data
indicate that the postischemic kidney has the ability to
restore its damaged nephron segmental structure and its
function, which is in good agreement with previously
published studies.19,20 Two days after ischemia, brush border
membranes are lost and cell debris is deposited in the lumen
of the proximal tubules. Seven days after ischemia, cast
formation is seen but brush border membranes are nearly
intact, and after 14 days the kidney is almost completely
recovered from injury.
Our RQ-PCR experiments demonstrated increased mRNA
levels of the transporter genes abcb1, abcb11, and abcc4, 7
days after inducing ischemia. The upregulation of abcb1 is
likely to be an adaptive response in the regeneration process
of the kidney after injury, and facilitates in this way the efflux
of waste products. Reoxygenation of the kidney following
ischemia is accompanied by the production of free radicals,
potentially leading to oxidative damage. In the brain, Abcb1
expression was also found to be upregulated after oxidative
stress.21 Abcb1 is upregulated in other stress situations as
well, like cadmium toxicity and after insulin stimulation;22,23
however, a downregulation was observed after chronic renal
failure.13 Under these conditions, the induction of the
abcb1a/1b transporter was suggested to be mediated through
signaling of the NF-kB pathway. It is known that reactive
oxygen species are formed in proximal tubules after
ischemia,24,25 which activate NF-kB.23,26 NF-kB gene expres-
sion was increased fourfold, 7 and 14 days after ischemia,
which suggests an activation of this pathway. This issue will
be addressed further in the near future.
In contrast to their mRNA levels, Western blot analysis,
however, showed that protein levels of abcb11 and abcc4 were
decreased after the ischemic insult, which indicated that these
transporters are regulated by a post-transcriptional mecha-
nism. This is in good agreement with previous observations
for abcb11 in the liver and abcc4 in the kidney.17,27,28 ABC
transporters expression is clearly regulated at the transcrip-
tional level,29 but several mechanisms of post-transcriptional
regulation have been described as well, including phosphory-
lation and protein routing.30,31 Using two different anti-
bodies, we showed by immunohistochemistry that abcb11
localizes to the apical membrane of the proximal tubular cells
of the kidney. Abcb11 has been studied intensively in the liver
where it is localized to the canalicular microvilli and to
subcanalicular vesicles of the hepatocyte.32 The efflux pump
mediates the ATP-dependent transport of conjugated mono-
valent bile salts, like glycocholate, taurochenodeoxycholate,
and tauroursodeoxycholate.33 In addition to these bile salts,
compounds like vinblastine, pravastatine, taxol, and calcein
have been reported to be Abcb11 substrates.34–36 Expression
in human and rat liver is variable under cholestatic
conditions and in advanced cirrhosis, in which the protein
and the gene were upregulated.37 In addition, Abcc4 was
upregulated in rat liver in obstructive cholestasis, whereas the
protein was downregulated in the kidney.17 As suggested for
Abcc4, the downregulation of abcb11 and abcc4 in the kidney
in the present study may be an adaptive response to increased
urinary substrates in renal failure.17
A downregulation after ischemia at the mRNA level was
established for abca3, abcc2, and abcg2. Abca3 and abcc2
protein levels were also decreased, in contrast to abcg2, which
was upregulated. Abca3 is expressed in the lung in the
alveolar type II cells, where it is supposed to play an
important role in the formation of pulmonary surfactant.38
Mutations in the human ABCA3 transporter have been
identified as a cause of acute respiratory distress syndrome
and can cause fatal surfactant deficiency in newborns.39 Our
data demonstrate that abca3 is highly expressed in the kidney
and that it is localized in the peritubular membranes, the
apical membranes of the proximal tubule, and in Bowman’s
capsule of the kidney. We can only speculate about the
function of the transporter in the kidney. ABCA3 likely plays
a role in lipid homeostasis, as it closely resembles other
ABCA family members that are known to transport
phospholipids. Reorganization of membrane lipids may be
an important function in the regeneration process of
damaged tissue.40
Abcc2 was downregulated after ischemia at both the
mRNA level and protein levels. This is different from the
study by Laouari et al.,13 who found an increase in Abcc2
after chronic renal failure; however, a downregulation is in
agreement with our findings in killifish renal tubules
after short-term exposure to nephrotoxic compounds.41,42
Remarkably, in liver failure, the transport protein is down-
regulated in the hepatocyte but upregulated in the kidney,
probably to facilitate the renal excretion of accumulating bile
salts.43,44 The expression of Abcc2 in the liver is under the
control of nuclear receptor activation, which is impaired
during cholestasis,29,37 but post-transcriptional mechanisms
of downregulation have been reported as well.31 Similar to
abcc4, the expression of abcc2 in liver opposes from those in
the kidney in liver failure, indicating that regulation of
transport proteins in the kidney is clearly distinct from the
mechanisms observed in the liver.
Abcg2 or Breast Cancer Resistance Protein 1 is highly
expressed in the mouse kidney and is known to transport
several anticancer drugs, like methotrexate, topotecan, and
doxorubicin.45 After inducing an ischemic insult, mRNA
levels were downregulated in contrast to the protein levels
that were upregulated. Its localization in the apical mem-
brane of renal proximal tubules and substrate specificity
suggest that upregulation of abcg2 after injury is an adaptive
response to accumulating harmful compounds that have to
be excreted into urine. In addition to its role in detoxification
through efflux, ABCG2 has been shown to be a determinant
in the side population phenotype of progenitor cells,46,47 has
been associated with regeneration and repair of skeletal
muscle and heart tissue, and it was suggested that the protein
protects cells from hypoxic damage by controlling porphyrins
and/or heme levels.6 Because of its high expression in the
mouse kidney and upregulation after ischemic–reperfusion
damage, we speculate that abcg2 may have a role in tissue
2190 Kidney International (2006) 69, 2186–2193
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defense and regeneration by cell differentiation in the kidney
as well.
In conclusion, our results show for the first time
expression and subcellular localization of abcb11 and abca3
in the kidney. Several transporter genes and proteins appear
to be differentially regulated after renal injury, which might
be associated with the renal regeneration process. Further
research is needed to elucidate the functional role of the
transporters in renal tissue repair and regeneration.
MATERIALS AND METHODS
Materials
Primer and probe sets for RQ-PCR were purchased from Applied
Biosystems (Zwijndrecht, The Netherlands). Primers for PCR
experiment were obtained from Biolegio (Malden, The Nether-
lands). Paraplast was obtained from Amsterstad (Amsterdam, The
Netherlands). Nitrocellulose membranes were acquired from
Amersham (Buckinghamshire, UK). Vectashield, mounting med-
ium, normal goat serum, avidin and biotin, and the vectastain ABC
kit were obtained from Vector Laboratories Inc. (Burlingame, CA,
USA). Antibody directed against ABCB1 (C219), and peroxidase-
labeled and biotinylated secondary antibodies were purchased from
Dako Cytomation (Heverlee, Belgium). Secondary fluorescent
antibodies were obtained from Molecular Probes Diaminobenzidine
chromogene was acquired from Sigma-Aldrich (Zwijndrecht,
Leiden, The Netherlands). The antibody directed against abcg2
was obtained from Kamiya Biomedical Company (Seattle, WA,
USA). The abca3 antibody was a kind gift from Dr Nobohiro Ban
(Akita, University School of Medicin, Akita, Japan). Antibodies
directed against abcb11 were obtained from Kamiya Biomedical
Company (Seattle, WA, USA) and from Professor Dr Bruno Stieger.
The antibody used for heparan sulfate staining was obtained from
Dr TH van Kuppevelt48 and the antibody against Na-K-ATPase was
from Dr JB Koenderink.18 All other chemicals used were of the
highest purity available and were obtained from Sigma-Aldrich
(St Louis, MO, USA).
Animals and ischemia induction
All procedures involving animals were approved by the Animal
Experimental Committee of the Radboud University Nijmegen.
Male FVB (Friend leukaemia virus B strain) mice (6–8 weeks) were
obtained from Charles River (Germany), and were housed under
routine laboratory conditions at the Central Animal Facility
Nijmegen. Mice were anesthesized using isoflurane and ischemia
was induced by bilateral clamping of the renal artery and vein for
30 min; control mice were sham operated. Mice were placed in
metabolic cages 2, 7, and 14 days after inducing ischemia to collect
urine and blood. Mice were killed by exsanguination. Kidneys were
removed and divided in two parts: one part was used for histological
examination and was fixed in Bouin’s solution. The other part was
used for immunohistochemistry, RNA, and membrane isolation and
was stored at 801C until further use. Serum creatinine levels were
determined using the Jaffe´ method.49
RNA isolation and cDNA reaction
RNA isolation was performed using the micro-dismembrator
(Sartorius BBI Systems GmbH, Melsungen, Germany). Total RNA
was isolated with Trizol reagent (Invitrogen, Breda, The Nether-
lands). RNA material from 16 mice was pooled in two groups and
used for reverse transcription in duplicate. Reverse transcription was
performed in a total mixture of 20 ml containing 50 mM Tris-HCl
(pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM dithiothreitol, 12.5 mM
dNTP mix, 200 U Mo-MLV reverse transcriptase (Invitrogen, Breda,
The Netherlands), 20 U RNAsin (Promega, Madison, WI, USA), and
5 mg of random hexamers (Pharmacia, Uppsala, Sweden). This
reaction mixture was incubated at 201C for 10 min, at 421C for
45 min, and at 951C for 10 min.
Quantitative PCR
For RQ-PCR, two pooled samples obtained from 16 different mice
were used. RQ-PCR was performed in duplo using the ABI/PRISM
7900HT Gene Expression Micro Fluidic Card (Applied Biosystems,
Foster City, CA, USA) according to the manufacturer’s instructions.
Primer and probe set ID numbers are given in Table 1. Abcc4 was
performed separately because it was not available at the Micro
Fluidic Card, and the utilized primers and probe were designed
by PrimerExpress Software (version 1.5, Applied Biosystems, Foster
City, CA, USA). The primers used were as follows: mMRP4_RT_Fw,
50-CTGCAGGACGCCAACCTCTG-30; mMRP4_RT_Rev, 50-CTT
CTTCCAGTCTCCGCTTATGA-30. Probe sequence was TET-50-
CGCGCGTGTTCTTCTGGTGGC-30-TAMRA (Applied Biosystems,
Zwijndrecht, The Netherlands). cDNA amplification was performed
with TaqMans Universal PCR Master Mix (Applied Biosystems,
Zwijndrecht, The Netherlands), 5 pmol of TET-labeled probe, and
15 pmol of forward and reverse primer in a total reaction volume of
25 ml. The thermal cycling conditions were 2 min at 501C and 10 min
at 951C, followed by 40 cycles of 9 s at 951C and 1 min at 601C. PCR
reactions were analyzed using either ABI PRISM 7900HT Sequence
Detection System or the 7700 Sequence Detection System (Applied
Biosystems, Foster City, CA, USA). For normalization, the house-
keeping genes glyceraldehyde-3-phosphate dehydrogenase, glucur-
onidase, and hypoxanthine guanine phosphoribosyl transferase 1
were used.
Membrane preparation and Western blotting
Total membrane fractions were obtained using the micro-dismem-
brator (Sartorius BBI Systems GmbH, Melsungen, Germany). To
this end, frozen kidneys were pulverized (2000 r.p.m., 30 s) and
transferred to ice-cold TS buffer (10 mM Tris-HCl, 250 mM sucrose)
including protease inhibitors (1 mM phenylmethylsulfonyl fluoride,
1 mg/ml aprotinin, 5 mg/ml leupeptin, 1 mg/ml pepstatin, and 10 mM
E64). From these suspensions, a supernatant was prepared (12 000 g,
30 min, 41C), which was centrifuged for 75 min at 105 000 g at 41C.
The resulting pellet containing crude membrane fractions (30 mg)
was solubilized in Laemmli sample buffer, heated at 651C for 10 min,
separated on a 6 or 10% polyacrylamide gel, and transferred to
Hybond-C pure nitrocellulose membrane. Transfer of proteins was
confirmed by the reversible staining of the membrane with Ponceau
Red. Subsequently, the blot was blocked for 60 min with 5% nonfat
dry milk powder in Tris-buffered saline supplemented with 0.1%
Tween 20 (TBS-T), after which the blot was washed twice in TBS-T.
The membrane was incubated at 41C overnight with the primary
antibody: Abca3 diluted 1:1000,50 Abcb1a/b diluted 1:200, Abcb11
diluted 1:500, Abcc2 diluted 1:1000,51 Abcc4 diluted 1:1000,16 and
Abcg2 diluted 1:50. After two washes for 5 min with TBS-T, the blot
was blocked for 30 min as described above. The blot was then
washed twice with TBS-T and incubated at room temperature for
60 min with the secondary antibody goat anti-mouse, goat anti-
rabbit, and goat anti-rat diluted 1:5000. Finally, the blot was washed
twice for 5 min with TBS-T and TBS, respectively. Proteins were
visualized using enhanced chemiluminescence (Pierce, Rockford, IL,
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USA). For semiquantification, we measured the pixel intensity of the
bands using Scion image version beta 4.02 for Windows (Scion
Corp., Frederick, MD, USA).
Histological examination
For light microscopy, kidney fragments taken 2, 7, and 14 days after
inducing ischemia were fixed in Bouin’s solution, dehydrated, and
embedded in paraplast. Sections of 3 mm were stained with periodic
acid-Schiff.8
Immunohistochemistry
Serial tissue sections of 1.5 mm were obtained using a cryostat, air
dried, and fixed in acetone for 10 min. Again, slices were air dried
and incubated for 60 min with the first antibody in phosphate-
buffered saline supplemented with 1% bovine serum albumin. Slices
were rinsed with phosphate-buffered saline for 10 min and
incubated with the secondary antibody Alexa Fluor 488 or Alexa
Fluor 594 for 45 min, diluted 1:200. After rinsing, slices were
mounted in Vectashield mounting medium. For the antibodies
abcb11 and abcc4,16 slices of 4 mm were obtained using a cryostat
and fixed in acetone for 5 min. Endogenous peroxidase was
quenched by incubation with 5% H2O2 for 5 min. Sections were
air dried, incubated with normal goat serum for 10 min, and
incubated with the primary antibody in phosphate-buffered saline
and 1% bovine serum albumin overnight. Slices were rinsed with
phosphate-buffered saline and incubated with avidin for 10 min and
biotin for 10 min. Slices were rinsed and incubated with the
biotinylated goat anti-rabbit secondary antibody (dilution 1:200) for
30 min followed by incubation with the vectastain ABC kit for
45 min. Subsequently, color reaction was developed using diamino-
benzidine chromogene. Slices were counterstained with hematoxy-
lin, dehydrated, and mounted in mounting medium. Sections were
examined with a confocal laser-scanning microscope (CLSM; Leica
lasertechnik GmbH, Heidelberg, Germany).
Data analysis
Data are given as means7s.e. Mean values were considered to be
significantly different when Po0.05 by use of a Student’s t-test.
Software used for statistical analysis was GraphPad Prisms (version
4.00 for Windows; Graph Pad Software, San Diego, CA, USA).
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